InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
21.39
+1.42 (7.11%)
At close: Mar 6, 2026

InventisBio Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,37115,7547,6718,7067,636-
Market Cap Growth
61.27%105.38%-11.89%14.01%--
Enterprise Value
10,85814,2416,0716,7285,265-
Last Close Price
21.3927.2413.3015.1413.28-
PS Ratio
331.43422.0845.4546.92--
PB Ratio
7.439.464.244.363.45-
P/TBV Ratio
7.449.474.244.363.45-
EV/Sales Ratio
290.89381.5335.9736.27--
Debt / Equity Ratio
0.010.010.010.010.010.04
Net Debt / Equity Ratio
-0.91-0.91-0.92-0.95-1.00-1.02
Net Debt / EBITDA Ratio
4.864.866.045.924.291.95
Net Debt / FCF Ratio
--6.676.084.562.52
Asset Turnover
--0.080.08--
Quick Ratio
--20.6513.2920.177.37
Current Ratio
--20.7813.4120.417.50
Return on Equity (ROE)
-18.23%-18.23%-12.61%-13.48%-33.34%-42.22%
Return on Assets (ROA)
---8.60%-9.08%-20.63%-24.42%
Return on Capital Employed (ROCE)
---15.30%-16.30%-23.20%-51.70%
Earnings Yield
-2.56%-2.01%-3.13%-3.26%-6.33%-
FCF Yield
---3.25%-3.61%-6.35%-
Buyback Yield / Dilution
0.07%0.07%-0.26%-12.97%-10.91%0.25%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.